A reliability test of standard-based quantitative PCR: Exogenous vs endogenous standards

Molecular and Cellular Probes

Volumn 14, Issue 2, 2000, Pages 127-135

  Ke, L D ^a   Chen, Z ^a   Yung, W K A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cervical cancer; GAPDH; Glioma; Quantitative PCR; Reliability of exogenous vs endogenous standards; VEGF

Indexed keywords

RECOMBINANT DNA; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; STANDARD; UTERINE CERVIX CANCER;

EID: 0034091196     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.2000.0288     Document Type: Article

References (37)

1. Siebert P. D., Larrick J. W. Competitive PCR. Nature. 359:1992;557-558.
2. Ferre F. Quantitative or semi-quantitative PCR: reality vs myth. PCR Methods and Application. 2:1992;1-9.
3. Larrick J. W. The PCR Technique: Quantitative PCR. Eaton Publishing. 1997.
4. Orlanda C., Pinzani P., Pazzagli M. ÍDevelopments in quantitative PCR. Clinical and Chemical Laboratory Medicine. 36:1998;255-269.
5. Aggarwal S., Gollapudi S., Gupta S. ÍIncreased TNF-(-induced apoptosis in lymphocytes from aged human: changes in TNF-(-receptor expression and activation of caspases. The Journal of Immunology. 162:1999;2154-2161.
6. Tanimoto H., Underwood L. J., Shigenasa K. The matrix metalloprotease pump-1 (MMP-7, Matrilysin): a candidate marker/target for ovarian cancer detection and treatment. Tumor Biology. 20:1999;88-98.
7. Sturzenbaum S. R., Kille P., Morgan A. J. The identification, cloning and characterization of earthworm metallothionein. FEBS Letters. 431:1998;437-442.
8. Ohkusa T., Noma T., Ueyama T. Differences in sarcoplasmic reticulum gene expression in myocardium from patients undergoing cardiac surgery. Quantification of steady-state levels of messenger RNA using the reverse transcription-polymerase chain Íreaction. Heart & Vessels. 12:1997;1-9.
9. Regitz-Zag V., Fielitz J., Dreysse R., Hildebrandt A. G., Fleck E. Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure. Cardiovascular Research. 35:1997;99-105.
10. Bohnemeier H., Pinto Y. M., Horkay F. Endothelin-converting enzyme-1 mRNA expression in human cardiovascular disease. Journal of Cardiovascular Pharmacology. 31:1998;52-54.
11. Wei Q., Xu X., Cheng L., Legerski R. J., Ali-Osman F. Simultaneous amplification of four DNA repair genes and (-actin in human lymphocytes by multiplex reverse transcriptase-PCR. Cancer Research. 55:1995;5025-5029.
12. Wei Q., Bondy M. L., Mao L. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain Íreaction in human gliomas. Cancer Research. 57:1997;1673-1677.
13. Piatak MJr, Saag M. S., Yang L. C. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 259:1993;1749-1754.
14. Ke L. D., Adler-Storthz K., Clayman G. L., Yung A. W. K., Chen Z. Differential expression of epidermal growth factor receptor in human head and neck cancers. Head & Neck. 20:1998;320-327.
15. Becker-Andre M., Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Research. 17:1989;9437-9446.
16. Zachar V., Thomas R. A., Goustin A. S. Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples. Nucleic Acids Research. 21:1993;2017-2018.
17. Peccoud J., Jacob C. Theoretical uncertainty of measurements using quantitative polymerase chain reaction. Biophysical Journal. 71:1996;101-108.
18. Ke L. D., Fueyo J., Chen X. A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes. International Journal of Oncology. 12:1998;1391-1396.
19. Tsai J. C., Goldman C. K., Gillespie G. Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB and bFGF. Journal of Neurosurgery. 82:1995;864-873.
20. 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. Journal of Biological Chemistry. 271:1997;7151-7158.
21. Wang M., Doyle M. V., Mark D. F. Quantitation of mRNA by the polymerase chain reaction. Proceedings of National Academy of Sciences, USA. 86:1989;9717-9721.
22. Syvanen A. C., Bengtstrom M., Tenhunen J., Soderlund H. Quantification of polymerase chain reaction products by affinity-based hybrid collection. Nucleic Acids Research. 16:1988;11327-11338.
23. Chelly J., Kaplan J. C., Maire P., Gautron S., Kahn A. Transcription of dystrophin gene in human muscle and non-muscle tissue. Nature. 333:1988;858-860.
24. Heid C. A., Stevens J., Livak K. J., Williams P. M. Real time quantitative PCR. Genome Research. 6:1996;986-994.
25. Gibson U. E. M., Heid C. A., Willians P. M. A novel method for real time quantitative RT-PCR. Genome Research. 6:1996;995-1001.
26. Cross N. C. P. Quantitative PCR techniques and applications. British Journal of Haematology. 89:1995;693-697.
27. Nicoletti A., Sassy-Prigent C. An alternative quantitative polymerase chain reaction method. Analytical Biochemistry. 236:1996;229-241.
28. Yamato E., Ikegami H., Takekawa K. Internal marker for quantitative analysis of mRNA by reverse transcriptase-polymerase chain reaction in pancreatic beta cells. Diabetologia. 39:1996;747-748.
29. Savonet V., Maenhaut C., Miot F., Pirson I. Pitfalls in the use of several 'housekeeping genes' as standards for quantitation of mRNA: the example of thyroid cells. Analytical Biochemistry. 247:1997;165-167.
30. Bereta J., Bereta M. Stimulation of Íglyceraldehyde-3-phosphate dehydrogenase mRNA levels by endogenous nitric oxide in cytokine- activated endothelium. Biochemical and Biophysical ÍResearch Communications. 271:1995;363-369.
31. Kim J. W., Kim S. J., Han S. M. Increased glyceraldehyde-3-phosphate dehydrogenase gene Íexpression in human cervical cancers. Gynecologic ÍOncology. 71:1998;266-269.
32. Rondinelli R. H., Epner D. E., Tricoli J. V. Increased glyceraldehyde-3-phosphate dehydro- genase gene expression in late pathological stage human prostate cancer. Prostate Cancer & Prostatic Diseases. 1:1997;66-72.
33. Ripple M. O., Wilding G. Alteration of glyceraldehyde-3-phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cells. Cancer Research. 55:1995;4234-4236.
34. Soutar R. L., Dillon J., Ralston S. H. Control genes for reverse-transcription-polymerase chain Íreaction: a comparison of beta actin and glyceraldehyde phosphate dehydrogenase. British Journal of Haematology. 97:1997;239-251.
35. Ke L. D., Adler-Storthz K., Mitchell M. F., Clayman G. L., Chen Z. Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncology. 35:1999;415-420.
36. Lo Y. M. D., Chan L. Y. S., Lo K.-W. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal Ícarcinoma. Cancer Research. 59:1999;1188-1191.
37. Schnitzler M., Dwight T., Marsh D. J., Gaskin E. L., Robinson B. G. Quantitation of APC mRNA in human tissues. Biochem. Biophys. Res. Commun. 217:1995;385-392.